Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endogenex Access Study

NCT07197788 is registered in ClinicalTrials.gov with Endogenex, Inc. as lead sponsor.

NCT NCT07197788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07197788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endogenex Access Study
Lead sponsor
Endogenex, Inc.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 30, 2026
Completion date
November 30, 2027
Enrollment
50 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2, type 2 diabetes, type 2 diabetes mellitus, type2diabetes